---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013892"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2025-09-17T23:59:59+00:00"
generated_at: "2026-05-17T06:22:39.803618+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# bioAffinity Technologies announces 1-for-30 reverse stock split effective Sept 19, 2025

## Summary
- 1-for-30 reverse stock split effective at open of trading on Nasdaq on September 19, 2025.
- Post-split outstanding shares approximately 1,338,029; fractional shares paid in cash.
- Reverse split intended to bring Company into compliance with Nasdaq minimum bid price requirement.
- Proportionate adjustments to exercise prices and shares underlying stock options and warrants.
- CUSIP for common stock changes to 09076W307; trading symbol BIAF unchanged.

## SEC filing metadata
- accession: 0001493152-25-013892
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2025-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315225013892/0001493152-25-013892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315225013892/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013892
- JSON: https://secwatch.observer/filing/0001493152-25-013892.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.